SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 138.58 |
| Enterprise Value ($M) | 58.04 |
| Book Value ($M) | 174.96 |
| Book Value / Share | 4.12 |
| Price / Book | 0.79 |
| NCAV ($M) | 168.97 |
| NCAV / Share | 3.97 |
| Price / NCAV | 0.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.47 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.45 |
| Current Ratio | 6.45 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 200.40 |
| Assets | 206.39 |
| Liabilities | 31.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Redmile Group, LLC | 4.60 | -9.60 | |
| 13G/A | Blue Owl Capital Holdings LP | 7.93 | 8.01 | |
| 13G/A | ARK Investment Management LLC | 6.70 | 16.21 | |
| 13D/A | Biotechnology Value Fund L P | 24.50 | 13.57 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 27,308 | 133,701 | 20.42 | |
| 14,446 | 140,661 | 10.27 | |
| 11,469 | 53,729 | 21.35 | |
| 5,389 | 94,987 | 5.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RLYB – Rallybio Corporation | ROIV – Roivant Sciences Ltd. |
| RPRX – Royalty Pharma plc | RVMD – Revolution Medicines, Inc. |
| RXRX – Recursion Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io